Arterial Hypertension Induced by Erythropoietin and Erythropoiesis-Stimulating Agents (ESA)
Open Access
- 1 February 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 4 (2), 470-480
- https://doi.org/10.2215/cjn.05040908
Abstract
This review summarizes the evidence for a hypertensinogenic effect of Erythropoietin (Epo) in normal human subjects and predialysis, hemodialysis, and continuous ambulatory peritoneal dialysis (CAPD) patients. The possible mechanisms of Epo-induced hypertension are examined with in vivo animal and in vitro data, as well as pathophysiological human studies in both normal subjects and CKD patients. The evidence for a hypertensinogenic effect of erythropoiesis-stimulating agents (ESAs) in normal subjects, predialysis CKD, hemodialysis, and CAPD patients is compelling. Epo increases BP directly and notably independently of its erythropoietic effect and its effect on blood rheology. The potential for the development of future agents that might act as specific stimulators of erythropoiesis, devoid of direct hemodynamic side effects is underscored.Keywords
This publication has 69 references indexed in Scilit:
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomesKidney International, 2008
- C.E.R.A. Corrects Anemia in Patients with Chronic Kidney Disease not on DialysisClinical Journal of the American Society of Nephrology, 2008
- Morning blood pressure at home predicts erythropoietin-induced hypertension in patients with chronic renal diseasesClinical and Experimental Nephrology, 2007
- Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volumeThe Journal of Physiology, 2006
- Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retentionAmerican Journal of Physiology-Renal Physiology, 2006
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Editorials: Recombinant Human Erythropoietin: Has Treatment Reached its Full Potential?Seminars in Dialysis, 2006
- Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac diseaseKidney International, 1999
- Safety and efficacy of erythropoietin in children with chronic renal failurePediatric Nephrology, 1999
- Hemodynamics of Uremic AnemiaCirculation, 1971